Evidence map›Paper›PMID 38418532›Full record

ArticleScientific reports2024

LDCT screening results among eligible and ineligible screening candidates in preventive health check-ups population: a real world study in West China.

Ting Bao, Bingqing Liu, Ruicen Li, Zhenzhen Li, Guiyi Ji, Youjuan Wang, Hanwei Yang, Weimin Li, Wenxia Huang, Yan Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ting BaoHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Bingqing LiuWest China School of Public Health, Department of Epidemiology and Health Statistics, Sichuan University, Chengdu, 610041, China.
Ruicen LiHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Zhenzhen LiHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Guiyi JiHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Youjuan WangHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Hanwei YangHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Weimin LiDepartment of Pulmonary and Critical Care Medicine, Sichuan University West China Hospital, Chengdu, 610041, China.
Wenxia HuangHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China. huangwenxia331@scu.edu.cn.
Yan HuangHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China. huangyan_0819@163.com.
Huairong TangHealth Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, China. huairongtang1963@163.com.
West China Medical Center of Sichuan University · CNWest China Hospital of Sichuan University · CNSichuan University · CN

Funding

National Key R&D Program of China 2017YFC0907501National Key R&D Program of China 2017YFC0907504Sichuan Province Science and Technology Support Program 2022YFS0130Sichuan University West China Hospital Disciplinary Excellence 1.3.5 Project Lung Cancer Early Research and application of early diagnosis and treatment system-West China Lung Cancer Project No. ZYJC18001
6 · The paper itself

Abstract

To compare the LDCT screening results between eligible and ineligible screening candidates in preventive health check-ups population. Using a real-world LDCT screening results among people who took yearly health check-up in health management center of West China Hospital between 2006 and 2017. Objects were classified according to the China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version) eligibility criteria. Descriptive analysis were performed between eligible and ineligible screening candidates. The proportion of ineligible screening candidates was 64.13% (10,259), and among them there were 4005 (39.04%) subjects with positive screenings, 80 cases had a surgical lung biopsy. Pathology results from lung biopsy revealed 154 cancers (true-positive) and 26 benign results (false-positive), the surgical false-positive biopsy rate was 4.17%, and ineligible group (7.69%) was higher than eligible group (2.47%), P < 0.05. Further, in ineligible screening candidates, the proportion of current smokers was higher among males compared to females (53.85% vs. 4.88%, P < 0.05). Of the 69 lung cancer patients detected in ineligible screening candidates, lung adenocarcinoma accounts for a high proportion of lung cancers both in male (75.00%) and female (85.00%). The proportion of ineligible screening candidates and the surgical false-positive biopsy rate in ineligible candidates were both high in health check-ups population.

Indexed as

Adenocarcinoma of LungLung NeoplasmsEarly Detection of CancerFemaleHumansMaleMass ScreeningTomography, X-Ray ComputedFalse-positive biopsyIneligible screening candidatesLow-dose spiral CTLung cancer screening

Identifiers

PMID38418532
PMCPMC10902338
OpenAlexW4392234372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.